Company Filing History:
Years Active: 2003
Title: Jens-Kerim Ergüden: Innovator in CNS Disease Treatment
Introduction
Jens-Kerim Ergüden is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of central nervous system (CNS) diseases. His innovative work has the potential to impact the lives of many individuals suffering from cognitive disorders.
Latest Patents
Ergüden holds a patent for "3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases." This invention relates to novel compounds that can be used in the production of medicaments aimed at treating various CNS disorders, including Alzheimer's disease and other forms of dementia. The patent outlines the chemical structure and potential applications of these compounds, emphasizing their therapeutic benefits.
Career Highlights
Jens-Kerim Ergüden is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on developing innovative solutions for complex health issues. With a patent portfolio that includes 1 patent, Ergüden has established himself as a key player in the field of CNS research.
Collaborations
Throughout his career, Ergüden has collaborated with esteemed colleagues, including Toshiya Moriwaki and Chantal Fürstner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and development in the pharmaceutical industry.
Conclusion
Jens-Kerim Ergüden's contributions to the treatment of CNS diseases through his innovative patents highlight the importance of research and development in the pharmaceutical field. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the future.